Profile
Gene Kim worked as an Executive Director-Financial Planning & Analysis at Versartis, Inc. from 2013 to 2018.
He then served as a Vice President-Finance at Kaleido Biosciences, Inc. from 2018 to 2020.
Currently, he holds the position of Vice President-Finance at Dyne Therapeutics, Inc. Mr. Kim completed his undergraduate degree at the University of California, Los Angeles.
Former positions of Gene Kim
| Companies | Position | End |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 2019-12-31 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 2018-04-30 |
| DYNE THERAPEUTICS, INC. | Director of Finance/CFO | - |
Training of Gene Kim
| University of California, Los Angeles | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
- Stock Market
- Insiders
- Gene Kim
